Literature DB >> 8428354

Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma.

T Yoneda1, M Nakai, K Moriyama, L Scott, N Ida, T Kunitomo, G R Mundy.   

Abstract

Bone resorbing cytokines may be associated with abnormalities in bone cell function and calcium homeostasis in a number of pathological conditions. One of these cytokines is interleukin 6 (IL-6), which is a multifunctional cytokine which has been shown to be associated with increased formation of bone resorbing osteoclasts in vitro. In this report, we demonstrate that neutralizing antibodies to human IL-6 lower the blood calcium in nude mice carrying a human tumor associated with increased IL-6 production. There was no effect on blood calcium in hypercalcemic nude mice carrying tumors not associated with increased IL-6 production and normocalcemic tumor-bearing nude mice. These results suggest that increased production of IL-6 may contribute to disturbances in calcium homeostasis in some malignancies, and suggest that neutralization of IL-6 effects can lower the serum calcium in these tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428354

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.

Authors:  T Yamamoto; K Ozono; S Kasayama; K Yoh; K Hiroshima; M Takagi; S Matsumoto; T Michigami; K Yamaoka; T Kishimoto; S Okada
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 2.  Pancreatic cancer and hypercalcemia associated with von Recklinghausen's disease.

Authors:  M Yamamoto; S Nakano; M Mugikura; I Tachibana; Y Ogami; M Otsuki
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 3.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

Authors:  J de la Mata; H L Uy; T A Guise; B Story; B F Boyce; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.

Authors:  Yu-Chi Chen; Donna M Sosnoski; Ujjawal H Gandhi; Leah J Novinger; K Sandeep Prabhu; Andrea M Mastro
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

6.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.

Authors:  D H Schweitzer; I L Boxman; C W Löwik; J H van Krieken; M G Weissglas; R J Baatenburg de Jong; S E Papapoulos
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

8.  Circulating concentrations of interleukin-6 in cancer patients and their pathogenic role in tumor-induced hypercalcemia.

Authors:  B Vanderschueren; J C Dumon; V Oleffe; C Heymans; J Gérain; J J Body
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

9.  Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.

Authors:  E M Greenfield; S M Shaw; S A Gornik; M A Banks
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 10.  Management of paraneoplastic syndromes in lung cancer.

Authors:  Leno Thomas; Young Kwok; Martin J Edelman
Journal:  Curr Treat Options Oncol       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.